Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Description of key information

The test item methyl benzoate does not show an allergic potential to the skin.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
from 2012-04-11 to 2012-06-2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)
Species:
mouse
Strain:
CBA
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Laboratories BV, Maasheseweg 87c, 5804 AB Venray / Netherlands
- Age at study initiation: 8-11 weeks
- Weight at study initiation: 16.2-23.9 g
- Housing: group housing
- Diet (e.g. ad libitum): Teklad Global Rodent 2914C – Rezeptur 3255 GLP Batch 73/11 (Provimi Kliba AG, 4303 Kaiseraugst/Switzerland), available ad libitum.
- Water (e.g. ad libitum): Community tap water from Itingen/Switzerland, available ad libitum.
- Acclimation period: 6 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.5-20.4
- Humidity (%): 37.4-62.2
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
25, 50, 100 % (w/v) in vehicle
No. of animals per dose:
4
Details on study design:
RANGE FINDING TESTS:
- Compound solubility: The highest test item concentration which can be technically used was a 75% (w/w) solution in acetone:olive oil (4:1 v/v). As the test item is a well pipettable liquid, it was also tested neat (100%).
- Irritation: At the tested 50 and 100 % concentrations, the animals did not show any signs of irritation.
- Lymph node proliferation response: is expressed as the number of radioactive disintegrations per minute per lymph node (dpm/lymph node) and as the ratio of 3HTdR incorporated into lymph node cells of the test groups relative to that recorded for the control group (Stimulation Index S.I.). Before dpm/lymph node values were determined, the mean scintillation-background dpm was subtracted from test and control raw data.

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Topical application / Administration of 3HTdR / Determination of incorporated 3HTdR
- Criteria used to consider a positive response: A test item is regarded as a sensitizer in the LLNA if the following criteria are fulfilled:
- First, the exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the S.I.
- Second, the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.

TREATMENT PREPARATION AND ADMINISTRATION: Test item preparation was made freshly before each dosing occasion, no more than 4 hours prior to application to the ears.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
For the body weight mean values and standard deviations were calculated.
Key result
Parameter:
SI
Value:
1.22
Test group / Remarks:
25% test item
Key result
Parameter:
SI
Value:
1.26
Test group / Remarks:
50% test item
Key result
Parameter:
SI
Value:
2.98
Test group / Remarks:
100% test item

The following results were obtained for methyl benzoate using acetone:olive oil (4:1 v/v) as vehicle:

Test item concentration % (w/v)

Groups

Measurement dpm

Calculation

Result SI

dpm-BG

Number of lymph nodes isolated

dpm / lymph nodea)

--

BG I

1

--

--

--

--

--

BG II

1

--

--

--

--

--

Group 1

1120

1117

8

140

--

25

Group 2

1368

1365

8

171

1.22

50

Group 3

1408

1405

8

176

1.26

100

Group4

3330

3327

8

416

2.98

BG = Background (1 mL 5 % trichloroacetic acid) in duplicates

SI = Stimulation Index (Ratio = dpm/lymph node test item treated group / dpm/lymph node Group 1)

a) = Since the lymph nodes of the animals of a dose group were pooled, dmp/lymph node was determined by dividing the measured value by the number of lymph nodes pooled.

The EC3 value was not determined as no SI value was equal or above 3.

Interpretation of results:
GHS criteria not met
Conclusions:
The test item methyl benzoate was not a skin sensitizer in this assay.
Executive summary:

In order to study the possible contact allergenic potential of Methyl Benzoate, three groups of four female mice each were treated daily with the test item at concentrations of 25%, 50% (w/w) in acetone:olive oil (4:1 v/v) and 100% by topical application to the dorsum of each ear lobe for three consecutive days. A control group of four female mice was treated with the vehicle acetone:olive oil (4:1 v/v) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine, 3HTdR). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes were excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3HTdR measured in a β-scintillation counter. All treated animals survived the scheduled study period. Neither clinical signs on the ears of the animals nor systemic findings were observed during the study period. The results obtained [Stimulation Index (S.I.)] are reported in the following table. The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.

 

Test item concentration % (w/v)

SI

Group 2

25

1.22

Group 3

50

1.26

Group 4

100

2.98

EC3: -- %

A dose-response relationship was not observed. A calculation of the EC3 value was not performed. In conclusion, the EC3 value was not determined as no SI value was equal or above 3.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

Key study


A fully reliable study in vivo LLNA (Bernard 2012) concluded that methyl benzoate does not show a skin sensitisation potential.


Supporting information


An open epicutaneous test in vivo (Kecak 1985) it was shown that methyl benzoate has no skin-sensitising potential.



Justification for selection of skin sensitisation endpoint:
GLP study according to OECD TG 429 (Skin sensitisation: Local Lymph Node Assay).

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Skin sensitisation:


Based on the above-stated assessment of the skin sensitisation potential, methyl benzoate does not need to be classified according to CLP (Regulation (EC) No 1272/2008).